[] [MONTAGE TECHNOLOGY GROUP LIMITED 2013 PERFORMANCE INCENTIVE PLAN 1. PURPOSE OF PLAN Plan Company The purpose of this Montage Technology Group Limited 2013 Performance Incentive Plan (this 2. ELIGIBILITY Eligible Person Securities Act participant Subsidiary Board The Administrator (as such term is defined in Section 3.1) may grant awards under this Plan only to those persons that the Administrator]
[December 31, 2013 Jennifer Thompson, Accounting Branch Chief Sondra Snyder, Staff Attorney Andrew Blume, Staff Accountant Division of Corporate Finance 100 F Street, NE Re: Lentuo International Inc. Form 20-F for Fiscal Year Ended December 31, 2012 File No. 001-34987 Dear Ms. Thompson, Ms. Snyder and Mr. Blume: Set forth below are the Companys responses to the comments contained in]
[December 31, 2013 Jennifer Thompson, Accounting Branch Chief Sondra Snyder, Staff Attorney Andrew Blume, Staff Accountant Division of Corporate Finance 100 F Street, NE Re: Lentuo International Inc. Form 20-F for Fiscal Year Ended December 31, 2012 File No. 001-34987 Dear Ms. Thompson, Ms. Snyder and Mr. Blume: Set forth below are the Companys responses to the comments contained in]
[Pre-effective AmendmentNo. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046] [[Schiff Hardin Letterhead] December 31, 2013 Board of Directors Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province, P.R. of China, 712046 Re:Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable state securities or]
[This Form 6-K consists of: 1. 2. CONTINUING CONNECTED TRANSACTIONS HUANENG GROUP FRAMEWORK AGREEMENT - 1 -]
[Pre-effective AmendmentNo. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046] [[Schiff Hardin Letterhead] December 31, 2013 Board of Directors Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province, P.R. of China, 712046 Re:Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable state securities or]
[This Form 6-K consists of: 1. 2. CONTINUING CONNECTED TRANSACTIONS HUANENG GROUP FRAMEWORK AGREEMENT - 1 -]
[NEWS RELEASE CONTACT: Gary S. Maier Maier & Company, Inc. (310) 471-1288 HIGHWAY HOLDINGS RECEIVES OEM TOOLING ORDER FOR PLASTIC COMPONENTS FROM LEADING U.S. PRINTER COMPANY --Complements Its Existing Relationship as Metal Components Supplier-- HONG KONG – December 9, 2013 -- “This new additional business represents an expansion of an OEM relationship that has evolved since 2007. We are gratified]
